Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral oromucosal oxytocin adjunct trial in young children with autism spectrum disorder
ChiCTR2400090166Phase 2Recruiting
- Sponsor
- University of Electronic Science and Technology of China
- Start
- Sep 2024
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised trial of oxytocin in Autism Spectrum Disorder (ASD) (4 arms), sponsored by University of Electronic Science and Technology of China. Primary endpoints: Autism Diagnostic Observation Schedule - 2 score and Social Responsivity Scale-2 score. Started Sep 2024; status: recruiting.
02
Drugs
oxytocin
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on ChiCTR2400090166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400090166.